Floatz logo

Amitriptyline

Cerebral Palsy

Sathbhavana Brain ClinicSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Cerebral Palsy cohort.

Asset / SponsorPhaseRating
ROPIVACAINE
University of California, Los Angeles
Phase 4BB
Bxcl501
Joseph Cravero
Phase 4BB
LAMOTRIGINE
Sathbhavana Brain Clinic
Phase 4BB
Tetrabenazine
Sathbhavana Brain Clinic
Phase 4BB
TRIHEXYPHENIDYL
Sathbhavana Brain Clinic
Phase 4BB

View all 23 →

Same molecule, other indications

Amitriptyline is also rated in:

Depressive Disorder, MajorDormant
BBB
Indicative ·
77 / 100
View asset →
major depressive disorderDormant
BBB
Indicative ·
73 / 100
View asset →
EsketamineDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →